The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men

NACompletedINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
ObesityMetabolic SyndromeLifestyle InterventionPre Diabetes
Interventions
BEHAVIORAL

Minimal intensity intervention

The minimal intensity intervention control includes the Group Lifestyle Balance (GLB) videos (DVD or online), standardized messages, and access to a lifestyle coach if initiated by the participant.

BEHAVIORAL

HOMBRE

HOMBRE is a Group Lifestyle Balance (GLB)-based intervention tailored for men and available in 3 delivery modalities (coach-facilitated individual approach, coach-led online virtual groups, and coach-led in-person groups). A lifestyle coach will support men in making an informed choice of modality and will provide ongoing individualized feedback. All delivery modalities provide the same evidence-based curriculum and include self-monitoring and individualized feedback from the lifestyle coach.

Trial Locations (1)

94301

Palo Alto Medical Foundation, Palo Alto

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

University of Illinois at Chicago

OTHER

collaborator

RTI International

OTHER

collaborator

University of Pittsburgh

OTHER

collaborator

Arizona State University

OTHER

collaborator

Stanford University

OTHER

lead

Palo Alto Medical Foundation

OTHER

NCT03092960 - The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men | Biotech Hunter | Biotech Hunter